399 related articles for article (PubMed ID: 19794494)
1. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
2. Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus.
Lotti R; Shu E; Petrachi T; Marconi A; Palazzo E; Quadri M; Lin A; O'Reilly LA; Pincelli C
Front Immunol; 2018; 9():370. PubMed ID: 29535737
[TBL] [Abstract][Full Text] [Related]
3. Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.
O'Reilly LA; Hughes P; Lin A; Waring P; Siebenlist U; Jain R; Gray DH; Gerondakis S; Strasser A
Cell Death Differ; 2015 May; 22(5):767-78. PubMed ID: 25361085
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
[TBL] [Abstract][Full Text] [Related]
5. Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.
Jeong D; Kim HS; Kim HY; Kang MJ; Jung H; Oh Y; Kim D; Koh J; Cho SY; Jeon YK; Lee EB; Lee SH; Shin EC; Kim HM; Yi EC; Chung DH
Elife; 2021 Jul; 10():. PubMed ID: 34223817
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Bossaller L; Rathinam VA; Bonegio R; Chiang PI; Busto P; Wespiser AR; Caffrey DR; Li QZ; Mohan C; Fitzgerald KA; Latz E; Marshak-Rothstein A
J Immunol; 2013 Sep; 191(5):2104-14. PubMed ID: 23918976
[TBL] [Abstract][Full Text] [Related]
9. Preimplantation maternal stress impairs embryo development by inducing oviductal apoptosis with activation of the Fas system.
Zheng LL; Tan XW; Cui XZ; Yuan HJ; Li H; Jiao GZ; Ji CL; Tan JH
Mol Hum Reprod; 2016 Nov; 22(11):778-790. PubMed ID: 27475493
[TBL] [Abstract][Full Text] [Related]
10. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
Watanabe D; Suda T; Hashimoto H; Nagata S
EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of NF-kappaB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice.
Vallabhapurapu S; Ryseck RP; Malewicz M; Weih DS; Weih F
Eur J Immunol; 2001 Sep; 31(9):2612-22. PubMed ID: 11536159
[TBL] [Abstract][Full Text] [Related]
14. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
Djamali A; Odorico JS
Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.
Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K
Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028
[TBL] [Abstract][Full Text] [Related]
18. FasL shedding is reduced by hypothermia in experimental stroke.
Liu L; Kim JY; Koike MA; Yoon YJ; Tang XN; Ma H; Lee H; Steinberg GK; Lee JE; Yenari MA
J Neurochem; 2008 Jul; 106(2):541-50. PubMed ID: 18410517
[TBL] [Abstract][Full Text] [Related]
19. E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
Mustafa N; Mitxelena J; Infante A; Zenarruzabeitia O; Eriz A; Iglesias-Ara A; Zubiaga AM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008734
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
